Category: WFN1 Contributors

12317310 / 1729 POSTS
Yes, things continue to change all around us. Have you ever found yourself in a situation where you think there’s no way out? I bet you have. We’ve all been there. As I think back to the early days of COVID-19, we all had different perceptions, ...
By John Vandermosten, CFANASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT KOL Call Achieve Life Sciences (NASDAQ:ACHV) hosted a web conference last week featuring company management, equity analysts and key opinion leaders (KOLs) in the tobacco and ni ...
By M. MarinNYSE:TRC READ THE FULL TRC RESEARCH REPORT Housing Shortage Underscores Need for Environmentally Responsible Development Tejon Ranch Company (NYSE:TRC) is a real estate-development company that targets maximizing shareholder value through ...
By M. MarinNASDAQ:WINT READ THE FULL WINT RESEARCH REPORT Two Lead Drug Candidates; Multiple Programs Windtree Therapeutics, Inc. (NASDAQ:WINT) is a biopharma and medical device company developing therapies for a range of acute cardiovascular and pul ...
I love sales. I absolutely love it. I hope you love sales too. At this time of the year, I want to share with you 10 reasons why I love sales:1. It’s About Helping PeopleThat’s what sales is all about. Salespeople help every day. We g ...
By Lisa ThompsonOTC:LGIQ READ THE FULL LGIQ RESEARCH REPORT Today, we initiated research coverage on Logiq, Inc. (OTC:LGIQ). Logiq (fka Weyland Technologies) is a provider of a SaaS platform for small businesses to create their own mobile app for use ...
By Lisa ThompsonOTC:POETF | TSX:PTK.V READ THE FULL POETF RESEARCH REPORT While the most important milestone for POET (OTC:POETF) (TSX:PTK.V) since Q2 ended was the signing of its joint venture with Xiamen Sanan Integrated Circuit, in Q3 2020 the com ...
By David Bautz, PhDOTC:MATN READ THE FULL MATN RESEARCH REPORT We are initiating coverage of Mateon Therapeutics, Inc. (OTC:MATN) with a valuation of $0.40. Mateon is a biopharmaceutical company developing drug candidates for difficult to treat cance ...
It’s time to reflect on what people see versus what they feel. This is another Mornings with Mark. Over the last week, I’ve been in about seven different states. Yes, I have made some trips. As I write this, I am in the airport in Grand Ra ...
By David Bautz, PhDNASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Phase 3 ALS Trial Does Not Meet Primary Endpoint On November 17, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) announced topline results from the company’s Pha ...
12317310 / 1729 POSTS